Cannabics Pharmaceuticals Inc (OTCMKTS:CNBX) Updates On Commercialization Of CBD Personalized Diagnostics

Cannabics Pharmaceuticals Inc (OTCMKTS:CNBX) will launch personalized CBD anti-tumor tests for people suffering with cancer. The diagnostic tests use liquid biopsies of cancer patients. It uses CTC technology that accumulates cancer cells from cancer patients’ blood samples, and assesses their sensitivity to CBD compounds together with conventional chemotherapy drug. The details The study data allow […]